HKD 87.8
(1.8%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.18 Billion CNY | 67.05% |
2022 | 5.49 Billion CNY | 14.36% |
2021 | 4.8 Billion CNY | 24.63% |
2020 | 3.85 Billion CNY | 130.5% |
2019 | 1.67 Billion CNY | 156.7% |
2018 | 651.71 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 10.45 Billion CNY | 0.0% |
2023 FY | 9.18 Billion CNY | 67.05% |
2023 Q2 | 9.72 Billion CNY | 0.0% |
2023 Q4 | 9.18 Billion CNY | 0.0% |
2022 FY | 5.49 Billion CNY | 14.36% |
2022 Q2 | 5.84 Billion CNY | 0.0% |
2022 Q4 | 6.17 Billion CNY | 0.0% |
2021 FY | 4.8 Billion CNY | 24.63% |
2021 Q2 | 5.76 Billion CNY | 0.0% |
2021 Q4 | 5.87 Billion CNY | 0.0% |
2020 Q4 | 4.57 Billion CNY | 0.0% |
2020 FY | 3.85 Billion CNY | 130.5% |
2020 Q2 | 4.9 Billion CNY | 0.0% |
2019 Q4 | 1.87 Billion CNY | 0.0% |
2019 FY | 1.67 Billion CNY | 156.7% |
2019 Q2 | 711.32 Million HKD | 0.0% |
2018 FY | 651.71 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -2139.334% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 18.372% |